Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1
Dr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new treatment options for patients...
20 Tammi 13min
Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline
Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic ...
6 Tammi 22min
Management of Cancer During Pregnancy Guideline
Dr. Alison Loren and Dr. Ann Partridge share the latest guideline from ASCO on the management of cancer during pregnancy. They highlight the importance of this multidisciplinary, evidence-based guidel...
11 Joulu 202534min
Management of Antineoplastic Extravasation: ONS-ASCO Guideline
Dr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the management of antineoplas...
18 Syys 202513min
Postmastectomy Radiation Therapy: ASTRO-ASCO-SSO Guideline
Dr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated recommendations on to...
16 Syys 202515min
Geriatric Assessment Global Guideline
Dr. Cris Bergerot and Dr. Enrique Soto join the podcast to discuss the new global guideline on geriatric assessment. This guideline provides evidence-based, resource-stratified recommendations across ...
27 Elo 202516min
Oncology Medical Homes: ASCO-COA Standards Update
Ms. Kim Woofter and Dr. John Cox discuss the latest updates to the evidence-based standards on oncology medical homes developed by ASCO and COA. These standards serve as the basis for the ASCO Certifi...
21 Heinä 202516min
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2025.1 Part 2
Dr. Joshua Reuss joints that podcast to discuss the latest changes to the living guideline on stage IV NSCLC with driver alterations. He discusses the new evidence for NSCLC with EGFR mutations and NR...
17 Heinä 202515min
